NCT00985985View on ClinicalTrials.gov

Efficacy and Safety Study of Nicotine Mint Lozenge (2mg and 4mg) in Smoking Cessation

PHASE3CompletedINTERVENTIONAL

Enrollment

723

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions

Smoking

Interventions

DRUG

Nicotine

2 mg or 4 mg nicotine lozenge

DRUG

Placebo

placebo lozenge

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY